10 Nov., Kathmandu : Laxmi Bank signed Memorandum of Understanding (MOU)with Nepal Eye program Tilganga Institute of and Ophthalmology to support diagnosis treatment of Childhood Eye Cancer technically known as Retinoblastoma. Mr. Ajaya Bikram Shah, CEO of the bank and Mrs. Reeta Gurung, CEO of Tilganga Institute of Ophthalmology signed the MOU. The bank shall provide fund amounting NPR 500,000.00 as an initiative under Corporate Social Responsibility (CSR) for the diagnosis and treatment of Retinoblastoma patients from deprived financial background.
Retinoblastoma is a rare eye cancer of childhood that arises in the retina. It is the most common intraocular malignancy of infancy and childhood; with an incidence of1 in 15,000 to 1 in 18,000 live births worldwide, mostly occurring to children age from birth till 5 years. If the disease is diagnosed and treated on time, chances of salvage of life, eye and vision is very high. In Nepal, Tilganga Institute of Ophthalmology has started its treatment, which include Chemotherapy, Laser therapy, Plaque Brachy therapy and surgery where needed.
The bank’s approach is to support Sustainable Development Goals of Good Health and Well-being by providing financial support to the hospital for diagnosis and treatment of Childhood Eye Cancer.